Recross Cardio Announces the 25th Subject Treated in the Global PROTEA-PFO Clinical Program
Milestone highlights growing multicenter experience with Recross Cardio's novel PFO Sealing System NEW YORK, Oct. 5, 2026 /PRNewswire/ -- Recross Cardio Inc., a structural heart company pioneering novel membrane-based technologies for lifelong septal management, today announced the...